Nicoya Lifesciences

Nicoya Lifesciences is a biotech company in Kitchener, Canada, founded in 2012. It has raised $50.0M across 3 rounds, most recently a $20.0M Series A in December 2021.

Home - Nicoya Lifesciences Inc.

Headquarters
Kitchener, Ontario
Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$50.0M
Last Round
$20.0M Series ADec 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Nicoya Lifesciences develops platforms for scientists working across discovery, characterization, and quality, helping them generate reproducible biophysical insights. Its portfolio measures molecular function, structure, and stability. The company combines engineering expertise spanning nanotechnology and microfluidics with dedicated customer support to provide researchers with reliable data and intuitive tools.

Summary

It lists 51–200 employees. It has raised $50.0M in total across 3 rounds, most recently a $20.0M Series A round in Dec 2021.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2021
$20.0M

Sign up to see all 3 events

Funding: Series A. Amounts, valuations, and investors where available.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nicoya Lifesciences on Indexed.vc
<a href="https://indexed.vc/companies/nicoya-lifesciences"><img src="https://indexed.vc/api/badge/company/nicoya-lifesciences" alt="Nicoya Lifesciences on Indexed.vc" width="260" height="76" /></a>